Island Pharmaceuticals Limited (ASX:ILA)
Australia flag Australia · Delayed Price · Currency is AUD
0.4300
+0.0050 (1.18%)
Sep 2, 2026, 11:44 AM AEST

Island Pharmaceuticals Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.280.280.121.26--
Revenue Growth
349.73%137.71%-90.57%---
Gross Profit
-2.58-2.58-1.29-1.01-1.14-
Operating Income
-10.33-10.33-3.96-2.86-2.91-2.81
Net Income
-9.84-9.84-3.92-2.86-2.83-2.61
Earnings Per Share
-0.04-0.04-0.02-0.03-0.03-0.03
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
12.8712.877.251.6624.79
Total Debt
---0.42--
Net Cash (Debt)
12.8712.877.251.2424.79
Net Cash Growth
87.37%77.49%485.58%-38.03%-58.26%-25.90%
Net Cash Per Share
0.050.050.040.010.020.06

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-4.83-4.83-2.77-3.16-2.7-1.88
Free Cash Flow
-4.83-4.83-2.77-3.16-2.7-1.88
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
----80.14%--
Operating Margin
-3656.30%-3656.30%-3326.06%-227.00%--
Pretax Margin
-3482.66%-3482.66%-3296.73%-227.04%--
Profit Margin
-3482.66%-3482.66%-3296.73%-227.04%--

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-1.84----
PS Ratio
444.94397.83277.977.74--